Genetic Analysis Market worth USD 13 Billion by 2030, says

Selbyville, Delaware, Oct. 19, 2022 (GLOBE NEWSWIRE) —

The genetic analysis market value will surpass USD 13 billion by 2030, according to a new research report by Global Market Insights Inc.

Growing prevalence of gene mutations has fostered the adoption of diagnostic methods such as genetic analysis. Moreover, 50 out of 100 women with a mutation in the BRCA1 or BRCA2 gene are at risk of getting breast cancer by the age of 70 years. As a result of this rapid rise in the occurrence of gene mutations, genetic analysis and testing will become a critical part of treatment protocols for rare conditions.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5379

Genetic analysis market value from the predictive genetic testing segment crossed USD 305 million in 2021. Predictive testing is performed on patients before they showcase any disease symptoms. This is useful in the diagnosis of patients with a family history of any treatable genetic disease. Increasing awareness of the benefits of routine testing will also support the adoption of advanced tests such as predictive gene testing.

The reagents & kits product segment accounted for more than 57% business share in 2021. An assay kit consists of different materials and reagents to easily perform assay functions and obtain expected results as per the standard experimental operating procedure. The reagents in the genome kits can be used for one or several steps of dissolution or dilution before use.

Browse key industry insights spread across 247 pages with 361 market data tables & 17 figures & charts from the report, “Genetic Analysis Market Size By Product, Test, Application, Technology, End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/genetic-analysis-market

Genetic analysis market from others…